UnitedHealth Group (NYSE:UNH) Stock Price Up 1.3% Following Dividend Announcement

UnitedHealth Group Incorporated (NYSE:UNH)’s share price was up 1.3% during mid-day trading on Wednesday after the company announced a dividend. The company traded as high as $416.02 and last traded at $409.6340. 9,517,059 shares traded hands during trading, an increase of 31% from the average session volume of 7,241,977 shares. The stock had previously closed at $404.44.

The newly announced dividend which will be paid on Tuesday, December 15th. Stockholders of record on Monday, December 7th will be given a dividend of $2.32 per share. This represents a $9.28 dividend on an annualized basis and a dividend yield of 2.4%. The ex-dividend date of this dividend is Monday, December 7th. UnitedHealth Group’s payout ratio is presently 53.00%.

Analyst Upgrades and Downgrades

A number of research analysts recently issued reports on the company. BMO Capital Markets set a $512.00 price objective on UnitedHealth Group in a research note on Tuesday, July 21st. DA Davidson set a $512.00 price target on shares of UnitedHealth Group in a report on Tuesday, July 21st. Robert W. Baird dropped their price target on shares of UnitedHealth Group from $453.00 to $427.00 and set a “neutral” rating for the company in a research report on Wednesday, October 14th. Erste Group Bank downgraded shares of UnitedHealth Group from a “buy” rating to a “hold” rating in a research report on Thursday, August 27th. Finally, Oppenheimer lifted their target price on shares of UnitedHealth Group from $420.00 to $500.00 and gave the company an “outperform” rating in a research note on Friday, July 17th. Twenty investment analysts have rated the stock with a Buy rating and eight have issued a Hold rating to the stock. According to MarketBeat, the company has an average rating of “Moderate Buy” and an average target price of $463.93.

UnitedHealth Group Stock Down 0.4%

The company has a current ratio of 0.74, a quick ratio of 0.78 and a debt-to-equity ratio of 0.66. The firm has a market capitalization of $353.16 billion, a P/E ratio of 22.51, a P/E/G ratio of 1.48 and a beta of 0.51. The company has a 50 day simple moving average of $390.62 and a two-hundred day simple moving average of $364.03.

UnitedHealth Group (NYSE:UNH) last released its quarterly earnings data on Tuesday, October 13th. The healthcare conglomerate reported $4.69 earnings per share (EPS) for the quarter, beating the consensus estimate of $4.14 by $0.55. UnitedHealth Group had a net margin of 3.53% and a return on equity of 17.95%. The firm had revenue of $112.72 billion for the quarter, compared to analysts’ expectations of $111.31 billion. During the same quarter last year, the business posted $2.59 earnings per share. The company’s revenue for the quarter was down .4% compared to the same quarter last year. UnitedHealth Group has set its FY 2026 guidance at 20.500- EPS. On average, equities analysts predict that UnitedHealth Group Incorporated will post 20.61 EPS for the current fiscal year.

UnitedHealth Group News Roundup

Here are the key news stories impacting UnitedHealth Group this week:

• Positive Sentiment: ETFs purchased $56.4 million of UNH shares on Nov. 4, a potentially supportive demand signal. ETFs Are Buying UnitedHealth (UNH) on Nov. 4
• Positive Sentiment: UnitedHealth’s Q3 adjusted EPS of $4.69 topped analyst expectations, and a recent earnings analysis said the results bolstered confidence in a margin recovery. UnitedHealth (UNH) Q3 Earnings Lift Confidence In Margin Recovery
• Positive Sentiment: A Zacks article characterized Wall Street analysts’ view of UNH as a Buy, offering a favorable sentiment signal, though the article summary did not cite a specific new rating change. Wall Street Analysts See UnitedHealth (UNH) as a Buy: Should You Invest?
• Positive Sentiment: The company declared a quarterly dividend of $2.32 per share, equivalent to $9.28 annually and a reported yield of 2.3%. UnitedHealth Group Declares Quarterly Dividend Of $2.32 Per Share
• Negative Sentiment: Utilization and policy concerns remain an overhang for the company, highlighting uncertainty around medical costs and the regulatory environment. Utilization and Policy Concerns Weigh on UnitedHealth Group Incorporated (UNH)
• Negative Sentiment: Renewed calls for a regulatory review of UnitedHealth’s business scale, alongside warnings that AI could disrupt large healthcare companies, add longer-term risk concerns. UnitedHealth Group (UNH) Draws Breakup Pressure As AI Threat Enters The Story

Insider Buying and Selling at UnitedHealth Group

In other news, CEO Patrick Conway sold 1,169 shares of UnitedHealth Group stock in a transaction dated Friday, August 21st. The stock was sold at an average price of $390.00, for a total value of $455,910.00. Following the sale, the chief executive officer directly owned 15,328 shares of the company’s stock, valued at approximately $5,977,920. The trade was a 7.09% decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. 0.19% of the stock is currently owned by insiders.

Hedge Funds Weigh In On UnitedHealth Group

Several institutional investors have recently added to or reduced their stakes in the company. Financial Freedom LLC acquired a new stake in shares of UnitedHealth Group in the 3rd quarter worth $163,000. Valmark Advisers Inc. grew its holdings in shares of UnitedHealth Group by 8.2% in the third quarter. Valmark Advisers Inc. now owns 5,860 shares of the healthcare conglomerate’s stock valued at $2,151,000 after purchasing an additional 446 shares during the period. Money Concepts Capital Corp increased its position in UnitedHealth Group by 8.1% during the third quarter. Money Concepts Capital Corp now owns 12,879 shares of the healthcare conglomerate’s stock worth $4,728,000 after purchasing an additional 963 shares during the last quarter. Allworth Financial LP raised its stake in UnitedHealth Group by 7.3% during the third quarter. Allworth Financial LP now owns 94,771 shares of the healthcare conglomerate’s stock worth $34,789,000 after purchasing an additional 6,462 shares during the period. Finally, Fisher Asset Management LLC boosted its holdings in UnitedHealth Group by 19.2% in the 3rd quarter. Fisher Asset Management LLC now owns 10,829,637 shares of the healthcare conglomerate’s stock valued at $3,975,343,000 after purchasing an additional 1,747,368 shares during the last quarter. Hedge funds and other institutional investors own 87.86% of the company’s stock.

About UnitedHealth Group

UnitedHealth Group is a diversified health care company that provides health benefits and health services through two main businesses: UnitedHealthcare and Optum. UnitedHealthcare offers health insurance and related benefit plans to individuals, employers and government programs, including Medicare and Medicaid.

Optum provides services across the health care system, including care delivery, pharmacy services, pharmacy benefit management, health technology and data analytics. Its businesses serve consumers, health care providers, employers, health plans and government organizations.

Founded in 1977 as United HealthCare Corporation, the company is headquartered in Minnetonka, Minnesota.